Capsule in Medical Technology
Navigation Links
Capsule in Medical Technology
... a phase one clinical
trial of AOBO-001, an oral capsule developed from traditional Chinese ... currently manufactures and markets the oral capsule in China under
the Cease Enuresis Oral capsule brand, which was approved by China's State
Food ...
... to evaluate the safety, tolerability and efficacy of its oral insulin capsule ORMD-0801. OnQ Consulting, a clinical research organization (CRO) located ... through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's ...
... with results previously presented with twice-daily dosing of the capsule formulation in the same study. All dosing regimens tested in the study ... tablet formulation, and patients receiving 400 mg twice daily with the capsule formulation, experienced a 1.8 - 1.9 log median reduction in plasma viral ...
... AEROLIZER should not be used to treat acute symptoms. Acute symptoms should be treated with fast-acting rescue inhalers. Do not use more than one capsule twice daily. FORADIL AEROLIZER should be used with caution in patients with cardiovascular disorders. FORADIL AEROLIZER is not a substitute for ...
... via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at ...
... gastrointestinal system. About Traficet-EN(TM) (CCX282-B) Traficet-EN is a small molecule, orally-available drug that is administered in capsule form and which is believed to control the inappropriate immune system response underlying inflammatory bowel disease (IBD) by blocking the CCR9 ...
... sample packs to clearly demonstrate the rapid relief and tolerability of RAPAFLO(TM)." The product label provides that one 8 mg RAPAFLO(TM) capsule be taken once daily with a meal. Stocking efforts have ensured the product will be available immediately by prescription at retail pharmacies ...
... and Outlook(R) Safety Infusion Systems using two-way communication with numerous vendors including Cerner, GE Centricity, Draeger, Philips, capsule and more. "We look forward to the opportunity to interact with other healthcare professionals and demonstrate our solutions in the kind of ...
... with our colleagues," said Nadav Kidron, Oramed CEO. "As we indicated at the completion of the study, the trial demonstrated that the oral insulin capsule had a good safety profile and was well tolerated and effective in lowering blood glucose levels in patients with type 2 diabetes." Oramed's ...
... TEMODAR Capsules should not be opened or chewed. If capsules are accidentally opened or damaged, rigorous precautions should be taken with the capsule contents to avoid inhalation or contact with the skin or mucous membranes. The effectiveness of TEMODAR in children has not been ...
... in 5-15% of subjects in clinical studies with Durezol included corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, and blepharitis. Other ocular adverse reactions occurring in 1-5% ...
... ALO-01 capsules for priority review. The priority review status provides for a review period of six months from the date of submission. The ALO-01 capsule NDA was submitted on June 30, 2008. In the United States, pain is a serious, undertreated public health problem, with 19 percent of American adults ...
... particular interest here is the effect addressing deficiencies in DHA may have on brain health as well as the brains of future generations." Each capsule of Animi-3 contains 500 mg of omega-3, (350 mg of DHA), 1 mg of folic acid, 12.5 mg of B6, and 12 mcg of B12. For more information, visit ....
... in chemokine-based therapeutics." About CCX282-B (Traficet-EN(TM)) Traficet-EN is a small molecule, orally-available drug that is administered in capsule form and which controls the inappropriate immune system response underlying inflammatory bowel disease (IBD) by blocking the CCR9 chemokine receptor. ...
... Doses in Patients with PAH, Dr. R. James White of the University of Rochester presented data from a 12-patient study showing that a sustained-release capsule of treprostinil administered twice daily allowed patients to maintain consistent therapeutic levels of treprostinil in their bloodstreams in an ...
... an extended-release opioid, morphine sulfate, with a sequestered core of naltrexone, an opioid antagonist, which is designed to be released if the capsule is tampered with by crushing, chewing or dissolving, thereby significantly reducing the euphoric effect of the opioid. According to Phase I study ...
... HCV compounds of different mechanisms of action. In the Phase 1b study, four cohorts of treatment-nave patients received ITMN-191 in a gelatin capsule every 12 hours or every 8 hours with food for a period of 14 days. In addition, a single cohort of treatment-experienced chronic hepatitis C patients ...
... dosing has begun in a clinical study to confirm the full antiplatelet activity of its novel combination medicine CGT-2168. CGT-2168 is a once-daily capsule that combines clopidogrel (currently marketed by Bristol-Myers Squibb Co. and Sanofi-Aventis as Plavix(R)) with a gastroprotectant (omeprazole) to ...
... exposure-dependent reduction in serum uric acid (SUA). In the dose group that resulted in the highest plasma drug levels (400 mg modified-release capsule twice daily), there was a 50.9% placebo-adjusted reduction in SUA (p < 0.001). The following table summarizes the results by dose group. Effect ...
... in enthesitis and dactylitis, two common disease manifestations causing pain and swelling. Enthesitis, an inflammation of a tendon, ligament or joint capsule insertion to the bone and dactylitis, a swelling of digits in the hands or feet, are estimated to affect more than one-third of people with psoriatic ...
Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997
... (DLTs) for the agent when administered orally in capsule form every two weeks to patients with a diverse ... CYT997 given as an oral capsule every two ... CYT997 given as an oral capsule dose. ...Mayo Clinic Finds Capsule Endoscopy Can Detect Intestinal Damage Caused by Celiac Disease
... -- Mayo Clinic researchers have found that capsule endoscopy can provide a magnified view of the ... and a gastroenterologist at Mayo Clinic. The capsule is approximately the size of a large vitamin, and ... hours to move through the small intestine. As the capsule moves through the digestive tract, images ...... to evaluate the safety, tolerability and efficacy of its oral insulin capsule ORMD-0801. OnQ Consulting, a clinical research organization (CRO) located ... through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's ...
Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
... trial is focused on assessing the safety and efficacy of its oral insulin capsule on nine Type 1 diabetes patients. The start of this clinical trial on ... serious adverse events. "The commencement of trials of our oral insulin capsule on Type 1 diabetics signals another major step forward for our company in ...... with results previously presented with twice-daily dosing of the capsule formulation in the same study. All dosing regimens tested in the study ... tablet formulation, and patients receiving 400 mg twice daily with the capsule formulation, experienced a 1.8 - 1.9 log median reduction in plasma viral ...
Anti-Cancer Drug CYT997 Update
... intravenous administration -- continued dose-escalation in its Phase I capsule dosing study (oral administration) Phase II clinical programs 1. ... and clinical activities. Phase I clinical program 1. Phase I capsule clinical study Cytopia has continued to accelerate dose-escalation in ...Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
... address issues and or requests set forth in the December 12, 2007 indiplon capsule action letter from the FDA in a timely manner if at all; risk that the ... address issues and or requests set forth in the December 12, 2007 indiplon capsule action letter from the FDA in a manner acceptable to the FDA if at all; ...... AEROLIZER should not be used to treat acute symptoms. Acute symptoms should be treated with fast-acting rescue inhalers. Do not use more than one capsule twice daily. FORADIL AEROLIZER should be used with caution in patients with cardiovascular disorders. FORADIL AEROLIZER is not a substitute for ...
... via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at ...
... gastrointestinal system. About Traficet-EN(TM) (CCX282-B) Traficet-EN is a small molecule, orally-available drug that is administered in capsule form and which is believed to control the inappropriate immune system response underlying inflammatory bowel disease (IBD) by blocking the CCR9 ...
BIOCOM's 4th Annual DeviceFest Honors Companies
... to provide a unique safety solution to prevent accidental needlestick injuries. "The Far Out" award went to CVAC Systems, Inc for its unique capsule device focused on the application of its Cyclic Variations in Altitude Conditioning process to treat diseases and disorders associated with aging, ...New Study Shows Probiotic Strain Effective in Boosting Immune Response to Flu Virus
... increases in T-cell production of TNF-alpha, a key immune marker, versus control upon exposure to influenza A in healthy adults who consumed a daily capsule of Bacillus coagulans GBI-30, PTA-6086 for 30 days. While many health professionals believe that probiotics can help people who have specific ...... sample packs to clearly demonstrate the rapid relief and tolerability of RAPAFLO(TM)." The product label provides that one 8 mg RAPAFLO(TM) capsule be taken once daily with a meal. Stocking efforts have ensured the product will be available immediately by prescription at retail pharmacies ...
... and Outlook(R) Safety Infusion Systems using two-way communication with numerous vendors including Cerner, GE Centricity, Draeger, Philips, capsule and more. "We look forward to the opportunity to interact with other healthcare professionals and demonstrate our solutions in the kind of ...
... with our colleagues," said Nadav Kidron, Oramed CEO. "As we indicated at the completion of the study, the trial demonstrated that the oral insulin capsule had a good safety profile and was well tolerated and effective in lowering blood glucose levels in patients with type 2 diabetes." Oramed's ...
ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
... However, OGD proposes without explanation that a Q1Q2 standard developed for oral solutions will nonetheless apply to Vancocin, an oral capsule product. Then, OGD backs off the sameness supposedly ensured by the Q1Q2 standard, and permits generic applicants to vary their inactive ingredients ...Harvard Study Shows Folic Acid, B Vitamins in Animi-3(R) May Prevent Vision Loss
... B6, B12, and folic acid, can address deficiencies in these nutrients associated with eye problems, including dry eye and macular health." Each capsule of Animi-3 contains 500 mg of omega-3, (350 mg of DHA), 200 mg of phytosterols, 1 mg of folic acid, 12.5 mg of B6, and 12 mcg of B12. More ...Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
... via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at ...US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream
... of muscle tissue damage due to lactic acid build up. Glyc'n Go(TM) delivers more pure GlycoCarn(R) per serving than any other GPLC tablet or capsule on the market today. Glyc'n Go(TM) is the only chewable form of GlycoCarn(R) and has been proven to dissolve 26% faster than tablets, enabling the ...... TEMODAR Capsules should not be opened or chewed. If capsules are accidentally opened or damaged, rigorous precautions should be taken with the capsule contents to avoid inhalation or contact with the skin or mucous membranes. The effectiveness of TEMODAR in children has not been ...
... in 5-15% of subjects in clinical studies with Durezol included corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, and blepharitis. Other ocular adverse reactions occurring in 1-5% ...
Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
... in 5-15% of subjects in clinical studies with Durezol included corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, and blepharitis. Other ocular adverse reactions occurring in 1-5% ...Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
... in 5-15% of subjects in clinical studies with Durezol included corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, and blepharitis. Other ocular adverse reactions occurring in 1-5% ...Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
... days. A total of 60 patients have been randomised for this study. The key objective of the study is to assess the clinical efficacy of an oral capsule formulation of iclaprim as step-down therapy in comparison with IV vancomycin in the treatment of cSSSI. The primary endpoint is the clinical cure ...Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
... via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at ...... ALO-01 capsules for priority review. The priority review status provides for a review period of six months from the date of submission. The ALO-01 capsule NDA was submitted on June 30, 2008. In the United States, pain is a serious, undertreated public health problem, with 19 percent of American adults ...
Cytopia Commences Second Phase II Study in Brain Cancer
... administered by mouth. Preliminary data from the company's Phase I oral study indicates that the compound is well absorbed after administration in capsule form. This key finding differentiates CYT997 from other vascular disrupting agents currently in development which can only be administered ...REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted
... for moderate-to-severe chronic pain. About ORADUR(TM) Technology ORADUR is a proprietary technology designed to transform short-acting oral capsule dosage forms into sustained release oral products, with the added benefit of being less prone to abuse (e.g. by crushing or water extraction) than ...... particular interest here is the effect addressing deficiencies in DHA may have on brain health as well as the brains of future generations." Each capsule of Animi-3 contains 500 mg of omega-3, (350 mg of DHA), 1 mg of folic acid, 12.5 mg of B6, and 12 mcg of B12. For more information, visit ....
... in chemokine-based therapeutics." About CCX282-B (Traficet-EN(TM)) Traficet-EN is a small molecule, orally-available drug that is administered in capsule form and which controls the inappropriate immune system response underlying inflammatory bowel disease (IBD) by blocking the CCR9 chemokine receptor. ...
Arpida Enrols First Patients in "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
... Infections (cSSSI). Enrolment remains on track for completion in 2008. The key objective of the study is to assess the clinical efficacy of an oral capsule formulation of iclaprim as step-down therapy in comparison with a full course of intravenous (i.v.) treatment with vancomycin in the treatment of ...... Doses in Patients with PAH, Dr. R. James White of the University of Rochester presented data from a 12-patient study showing that a sustained-release capsule of treprostinil administered twice daily allowed patients to maintain consistent therapeutic levels of treprostinil in their bloodstreams in an ...
... an extended-release opioid, morphine sulfate, with a sequestered core of naltrexone, an opioid antagonist, which is designed to be released if the capsule is tampered with by crushing, chewing or dissolving, thereby significantly reducing the euphoric effect of the opioid. According to Phase I study ...
Pregnant Women Need Omega-3 to Boost Infant Development
... President Jack Schramm. "The DHA in Animi-3 is all natural and purified to eliminate any contaminants including those commonly found in fish." Each capsule of Animi-3 contains 500 mg of omega-3 acids, including 350 mg of DHA. For more information, visit http://www.animi-3.com . *docosahexaenoic acid ...... HCV compounds of different mechanisms of action. In the Phase 1b study, four cohorts of treatment-nave patients received ITMN-191 in a gelatin capsule every 12 hours or every 8 hours with food for a period of 14 days. In addition, a single cohort of treatment-experienced chronic hepatitis C patients ...
Diagnostic Center for Disease: Prostate Biopsy Spreads Prostate Cancer Cells
... cancer cells beyond the prostate when a biopsy is performed. An extensive review of the literature confirms that once a needle penetrates the capsule of an organ, a phenomenon called "needle tracking" takes place. When the needle is withdrawn from the targeted organ, the chance of spreading cancer ...... dosing has begun in a clinical study to confirm the full antiplatelet activity of its novel combination medicine CGT-2168. CGT-2168 is a once-daily capsule that combines clopidogrel (currently marketed by Bristol-Myers Squibb Co. and Sanofi-Aventis as Plavix(R)) with a gastroprotectant (omeprazole) to ...
... exposure-dependent reduction in serum uric acid (SUA). In the dose group that resulted in the highest plasma drug levels (400 mg modified-release capsule twice daily), there was a 50.9% placebo-adjusted reduction in SUA (p < 0.001). The following table summarizes the results by dose group. Effect ...
... in enthesitis and dactylitis, two common disease manifestations causing pain and swelling. Enthesitis, an inflammation of a tendon, ligament or joint capsule insertion to the bone and dactylitis, a swelling of digits in the hands or feet, are estimated to affect more than one-third of people with psoriatic ...
Other ContentscardiologycardiologycardiologycardiologycardiologytamponadecardiopulmonarycardiopulmonarycardiopulmonarycardiovascularcardiovascularcardiovascularcardiovascularcardiovascularcardiovascularcardiovascularcardioversionoiloiloiloiloiloiloiloilcastorcarotenecaroteneOther TagsMicroscopeMicroscopeMicroscopeMicroscope
(Date:12/16/2009)... microfossils found in ocean sediment cores is illuminating the ... critical period of Earth history. , Around 55 million ... the Earth,s poles are believed to have been free ... million years later, ice sheets covered Antarctica and continental ... from greenhouse to icehouse conditions resulted from decreasing greenhouse ...
(Date:12/16/2009)... Energy Steven Chu announced today the winners of the ... research and development supporting the Department of Energy and ... receive a gold medal, a citation and $50,000. ... Washington, DC early next year., "The contributions made by ... security of the United States are wide-ranging and meaningful," ...
(Date:12/16/2009)... and rituals can help them get psyched up for ... (NSAIDs), which many athletes gobble down before and during ... , "These agents are treatments for the symptoms of ... whose research at Indiana University focuses on musculoskeletal health ... exercise or train at a certain level, but pain ...
Breaking Biology News(10 mins):From greenhouse to icehouse -- reconstructing the environment of the Voring Plateau 2Secretary Chu announces 2009 Ernest Orlando Lawrence Award winners 2NSAIDs: Take 'em early and often when competing? Think again 2Edmond Scientific Company Rallies as Certifications 26 Assessments 28C 26A 29 Provider for HIEs Pursuing ARRA ONC Grants 55743 1Edmond Scientific Company Rallies as Certifications 26 Assessments 28C 26A 29 Provider for HIEs Pursuing ARRA ONC Grants 55743 2Noteworthy Medical Systems Demonstrates National Health Information Network 28NHIN 29 Interoperability 55739 1Noteworthy Medical Systems Demonstrates National Health Information Network 28NHIN 29 Interoperability 55739 2Noteworthy Medical Systems Demonstrates National Health Information Network 28NHIN 29 Interoperability 55739 3New Vision Device Passes Virtual Collision Test for People with Tunnel Vision 13741 1New Vision Device Passes Virtual Collision Test for People with Tunnel Vision 13741 2New Vision Device Passes Virtual Collision Test for People with Tunnel Vision 13741 3(Date:12/17/2009)... feature is by Devon Herrick, PhD, Senior Fellow at ... often assume they have little control over how much ... cannot be scheduled, doctors prescribe treatments and employers provide ... However, there are many overlooked ways to trim your ... ,, Cut your prescription costs: ...
(Date:12/17/2009)... OAKLAND, Calif., Dec. 17 Today, SEIU ... that Alameda County In-Home Supportive Service (IHSS) providers ... contract with the County that adds multiple layers ... and benefit levels, as well as granting additional ... joining the Governor,s desire to slash homecare provider ...
(Date:12/17/2009)... resilient, ‘two-in-one’ foam roller. This patented foam roller has one ... making it one of the most versatile foam rollers available. ... ... 17, 2009 -- The SMARTROLLER® from OPTP is ... foam roller has one side that is flatter and one ...
(Date:12/17/2009)... rewards eligible physicians meeting quality standards. Open to primary care ... for double-digit increases in reimbursement for commonly billed services, ... ... 16, 2009 -- Blue Cross and Blue Shield of ... health care quality in North Carolina by introducing a new ...
(Date:12/17/2009)... Calif., Dec. 17 It,s customary for the ... like any busy time of year, workouts often get ... according to celebrity fitness trainer Valerie Waters, it is ... out the window. That,s why California Raisins and Waters ... make wise choices during the holiday season and get ...
Breaking Medicine News(10 mins):Health News:Six Ways to Slash Your Health Costs 2Health News:Six Ways to Slash Your Health Costs 3Health News:Six Ways to Slash Your Health Costs 4Health News:New Alameda County IHSS Contract Sends Clear Message to Elected Leaders That Homecare Program Must Remain a California Priority 2Health News:OPTP Introduces the SMARTROLLER 2Health News:BCBSNC Rewarding Physicians for Better Care, Not More Care, Through Blue Quality Physician Program, 2Health News:BCBSNC Rewarding Physicians for Better Care, Not More Care, Through Blue Quality Physician Program, 3Health News:Celebrity Fitness Trainer Valerie Waters and California Raisins Offer Advice on How to Jump Start the New You in the New Year 2Health News:Celebrity Fitness Trainer Valerie Waters and California Raisins Offer Advice on How to Jump Start the New You in the New Year 3[0] Six Ways to Slash Your Health Costs[0] New Alameda County IHSS Contract Sends Clear Message to Elected Leaders That Homecare Program Must Remain a California Priority[0] OPTP Introduces the SMARTROLLER [0] BCBSNC Rewarding Physicians for Better Care, Not More Care, Through Blue Quality Physician Program,[0] Celebrity Fitness Trainer Valerie Waters and California Raisins Offer Advice on How to Jump Start the New You in the New Year
MetaphaseMethylationMicrofilamentMicroevolutionMicrogametophyteMicronucleusMicromereMicropyleMicrosatelliteMicroscopeMicrosporeMicrosporangiumMicrotubulesMictic
Other Tagsvalve 2valve 3award 2award 3award 4award 5award 6dollars 2dollars 3dollars 4dollars 5dollars 6dollars 7dollars 8dollars 9dollars 10sustainable 2sustainable 3sustainable 4vaccinated 2vaccinated 3helpful 2helpful 3helpful 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |